» Articles » PMID: 27036040

The Roles of Tricellular Tight Junction Protein Lipolysis-stimulated Lipoprotein Receptor in Malignancy of Human Endometrial Cancer Cells

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Apr 2
PMID 27036040
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Lipolysis-stimulated lipoprotein receptor (LSR) has been identified as a novel molecular constituent of tricellular contacts that have a barrier function for the cellular sheet. LSR recruits tricellulin (TRIC), which is the first molecular component of tricellular tight junctions. Knockdown of LSR increases cell motility and invasion of certain cancer cells. However, the behavior and the roles of LSR in endometrial cancer remain unknown. In the present study, we investigated the behavior and roles of LSR in normal and endometrial cancer cells in vivo and in vitro. In endometriosis and endometrial cancer, LSR was observed not only in the subapical region but also throughout the lateral region as well as in normal endometrial epithelial cells in the secretory phase, and LSR in the cancer was reduced in correlation with the malignancy. Knockdown of LSR by the siRNA in cells of the endometrial cancer cell line Sawano, induced cell migration, invasion and proliferation, while TRIC relocalized from the tricellular region to the bicellular region at the membrane. In Sawano cells and normal HEEs, a decrease of LSR induced by leptin and an increase of LSR induced by adiponectin and the drugs for type 2 diabetes metformin and berberine were observed via distinct signaling pathways including JAK2/STAT. In Sawano cells, metformin and berberine prevented cell migration and invasion induced by downregulation of LSR by the siRNA and leptin treatment. The dissection of the mechanism in the downregulation of endometrial LSR during obesity is important in developing new diagnostic and therapy for endometrial cancer.

Citing Articles

Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a.

Zhu J, Wang T, Liu X, Lu T, Zhuo J, Li X J Neurooncol. 2025; .

PMID: 39992572 DOI: 10.1007/s11060-025-04976-4.


Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.

Arai W, Konno T, Kohno T, Kodera Y, Tsujiwaki M, Shindo Y Oncotarget. 2023; 14:261-275.

PMID: 36961882 PMC: 10038356. DOI: 10.18632/oncotarget.27728.


Atypical Macropinocytosis Contributes to Malignant Progression: A Review of Recent Evidence in Endometrioid Endometrial Cancer Cells.

Kohno T, Kojima T Cancers (Basel). 2022; 14(20).

PMID: 36291839 PMC: 9599675. DOI: 10.3390/cancers14205056.


LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer.

Saito K, Konno T, Kohno T, Shimada H, Matsuura M, Okada T Tissue Barriers. 2022; 11(3):2106113.

PMID: 35883247 PMC: 10364657. DOI: 10.1080/21688370.2022.2106113.


Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.

Nagase Y, Hiramatsu K, Funauchi M, Shiomi M, Masuda T, Kakuda M BMC Cancer. 2022; 22(1):679.

PMID: 35729527 PMC: 9210735. DOI: 10.1186/s12885-022-09789-6.


References
1.
Korompay A, Borka K, Lotz G, Somoracz A, Torzsok P, Erdelyi-Belle B . Tricellulin expression in normal and neoplastic human pancreas. Histopathology. 2012; 60(6B):E76-86. DOI: 10.1111/j.1365-2559.2012.04189.x. View

2.
Angelow S, Ahlstrom R, Yu A . Biology of claudins. Am J Physiol Renal Physiol. 2008; 295(4):F867-76. PMC: 2576152. DOI: 10.1152/ajprenal.90264.2008. View

3.
Kojima T, Kyuno D, Sawada N . Targeting claudin-4 in human pancreatic cancer. Expert Opin Ther Targets. 2012; 16(9):881-7. DOI: 10.1517/14728222.2012.708340. View

4.
Martin T, Jiang W . Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta. 2008; 1788(4):872-91. DOI: 10.1016/j.bbamem.2008.11.005. View

5.
Barone I, Catalano S, Gelsomino L, Marsico S, Giordano C, Panza S . Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. Cancer Res. 2012; 72(6):1416-27. PMC: 4123759. DOI: 10.1158/0008-5472.CAN-11-2558. View